ClinConnect ClinConnect Logo
Search / Trial NCT06387797

Primary and Secondary Prevention of Type 2 Diabetes Mellitus in Clark County

Launched by UNIVERSITY OF NEVADA, LAS VEGAS · Apr 23, 2024

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Pre Diabetes Primary Prevention Adults

ClinConnect Summary

This clinical trial, called the "Primary and Secondary Prevention of Type 2 Diabetes Mellitus in Clark County," is exploring how effective a nutrition education program can be in helping people at risk of developing type 2 diabetes. The study compares a standard cooking curriculum with an enhanced version that includes specific information about diabetes management. Participants will also wear continuous glucose monitors for 10 days to help track their blood sugar levels. The goal is to see if this program helps improve knowledge about healthy eating, encourages more fruit and vegetable consumption, and leads to better blood sugar control among participants.

To participate, individuals must be at risk for type 2 diabetes, which can be identified through factors like obesity, family history, or specific blood test results. Unfortunately, those who already have diabetes or certain health conditions cannot join this study. Participants can expect to attend cooking classes at the UNLV Nutrition Center for six weeks, where they will learn about healthy food choices and cooking techniques. This study is an important step in finding effective ways to prevent type 2 diabetes and improve overall health in the community.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • People with pre-diabetes, or those self-identifying as at-risk for type 2 diabetes mellitus (T2DM).
  • Risk for T2DM can be determined through indicators such as family history of T2DM, overweight or obesity, metabolic syndrome, HbA1c levels between 5.7% and 6.4%, or fasting blood glucose levels between 100 and 125 mg/dL. There is increased risk for T2DM among American Indian/Alaska Native, Black and Hispanic adults as compared with White and Asian adults; adults ages 25 and older with less than a high school education, as compared with those with higher education levels; and adults ages 25 and older with household incomes less than $25,000 as compared with those with higher income levels.
  • Exclusion Criteria:
  • People who have been diagnosed with T2DM or tested at an HbA1c% level that indicates T2DM. (\>6.4%) People who are non-English speaking (this is a feasibility/pilot study, if effective we will propose a fully-powered trial that we plan to translate into Spanish). The curriculum we are using has a Spanish version that we can make available if needed once a participant is enrolled. Additionally, the study coordinator is a student listed on this application who is fluent in Spanish and can help those with limited English capability to ensure participants understand the study and what is expected.
  • People who are unable to attend in-person cooking classes at the UNLV Nutrition Center for 6 weeks using their own means of transportation.
  • People who are unwilling to undergo multiple finger-sticks for determining HbA1c, lipids, and glucose levels.
  • Anyone who has been diagnosed with cardiovascular or metabolic diseases, and or using medications currently to control blood glucose, including Metformin or insulin.
  • People who have uncontrolled high blood pressure (SBP: \>=140/DBP \>=90) People who have implantable metal; (e.g., pacemaker) because body composition will be measured via bioimpedance.
  • People who are actively trying to lose weight, or currently enrolled in a weight loss program or other dietary intervention.
  • People who have dietary restrictions including those following a vegan diet, gluten-free diet, or with food allergies to any fruits or vegetables.

About University Of Nevada, Las Vegas

The University of Nevada, Las Vegas (UNLV) is a prominent research institution committed to advancing healthcare through innovative clinical trials. With a focus on multidisciplinary collaboration, UNLV engages in rigorous scientific inquiry to explore new treatments and interventions that address pressing health challenges. The university's dedicated faculty and state-of-the-art facilities foster an environment conducive to cutting-edge research, ensuring the highest standards of ethical practice and patient care. Through its clinical trials, UNLV aims to contribute to the body of medical knowledge while improving health outcomes for diverse populations.

Locations

Las Vegas, Nevada, United States

Patients applied

0 patients applied

Trial Officials

Sara K Rosenkranz, PhD

Principal Investigator

University of Nevada, Las Vegas

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported